visualizations
Kendrick, James Erasmus IV, MD, FACOG
Overview
overview
- Dr. James E Kendrick, MD, FACOG is board certified in gynecology oncologist in Orlando. Dr. Kendrick joined the Gynecologic Oncology Program at the Florida Hospital Cancer Institute in July of 2009. He graduated with honors from the University of Alabama School of Medicine. Dr. Kendrick then completed a four year residency in obstetrics and gynecology followed by a three year fellowship in gynecologic oncology at The University of Alabama at Birmingham. Dr. Kendrick is widely published in numerous academic journals, and currently serves as the principal investigator for all Gynecologic Oncology Group clinical trials available to our patients. His clinical interests include robotic surgery and the surgical and medical management of all gynecologic malignancies.
research areas
Affiliation
Member of
-
Clinical Program
-
Research Department
Publications
Most Recent Publications
-
2024Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 34:977-984.Full Text via DOI: 10.1136/ijgc-2024-005402 PMID: 38830645
-
2023Clinical outcomes analysis of neoadjuvant chemotherapy for locally advanced vulvar cancer. GYNECOLOGIC ONCOLOGY. S97-S97.Full Text via DOI: 10.1016/j.ygyno.2023.06.055
-
2023Analysis of "sandwich" chemo-radiation therapy for stage IIIC endometrial cancer. GYNECOLOGIC ONCOLOGY. S143-S143.Full Text via DOI: 10.1016/j.ygyno.2023.06.132
-
2023Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancer. GYNECOLOGIC ONCOLOGY. 175:93-96.Full Text via DOI: 10.1016/j.ygyno.2023.06.006 PMID: 37329874
-
2023Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer The Nonrandomized Phase 2 VIRO-15 Clinical Trial. JAMA ONCOLOGY. 9:903-908.Full Text via DOI: 10.1001/jamaoncol.2023.1007 PMID: 37227734
-
2022MALIGNANT PERITONEAL CYTOLOGIC CONTAMINATION WITH ROBOTIC HYSTERECTOMY FOR ENDOMETRIAL CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A93-A93.Full Text via DOI: 10.1136/ijgc-2022-igcs.204
-
2022Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial. CLINICAL CANCER RESEARCH. 28:4186-4193.Full Text via DOI: 10.1158/1078-0432.CCR-21-1733 PMID: 35917514
-
2022Corrigendum to "A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer" [Gynecologic Oncology 163 (2021) 481-489].. Gynecologic oncology. 401.Full Text via DOI: 10.1016/j.ygyno.2022.02.014 PMID: 35219528
-
2021Search for Lepton-Flavor Violation in Z-Boson Decays with tau Leptons with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 127.Full Text via DOI: 10.1103/PhysRevLett.127.271801 PMID: 35061407
-
2021A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer. GYNECOLOGIC ONCOLOGY. 163:481-489.Full Text via DOI: 10.1016/j.ygyno.2021.10.069 PMID: 34686353
-
2021ASO Visual Abstract: Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy-Recurrence Patterns, Risk Factors, and Survival. ANNALS OF SURGICAL ONCOLOGY.Full Text via DOI: 10.1245/s10434-021-11148-x PMID: 34850304
-
2021Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy: Recurrence Patterns, Risk Factors, and Survival. ANNALS OF SURGICAL ONCOLOGY.Full Text via DOI: 10.1245/s10434-021-11052-4 PMID: 34757549
-
2021Search for New Phenomena in Final States with Two Leptons and One or No b-Tagged Jets at root S=13 TeV Using the ATLAS Detector. PHYSICAL REVIEW LETTERS. 127.Full Text via DOI: 10.1103/PhysRevLett.127.141801 PMID: 34652194
-
2021Search for Displaced Leptons in root s=13 TeV pp Collisions with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 127.Full Text via DOI: 10.1103/PhysRevLett.127.051802 PMID: 34397238
-
2021Feasibility of a telemedicine lifestyle-based rehabilitation program (HEAL) for gynecologic cancer patients.. JOURNAL OF CLINICAL ONCOLOGY.Full Text via DOI: 10.1200/JCO.2021.39.15_suppl.e24033
-
2021Search for Dark Matter Produced in Association with a Dark Higgs Boson Decaying into (WW -/+)-W-+/- or ZZ in Fully Hadronic Final States from root s=13 TeV pp Collisions Recorded with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 126.Full Text via DOI: 10.1103/PhysRevLett.126.121802 PMID: 33834820
-
2021Longitudinal Flow Decorrelations in Xe plus Xe Collisions at root s(NN )=5.44 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 126.Full Text via DOI: 10.1103/PhysRevLett.126.122301 PMID: 33834811
-
2021Medium-Induced Modification of Z-Tagged Charged Particle Yields in Pb plus Pb Collisions at 5.02 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 126.Full Text via DOI: 10.1103/PhysRevLett.126.072301 PMID: 33666476
-
2020Observation and Measurement of Forward Proton Scattering in Association with Lepton Pairs Produced via the Photon Fusion Mechanism at ATLAS. PHYSICAL REVIEW LETTERS. 125.Full Text via DOI: 10.1103/PhysRevLett.125.261801 PMID: 33449771
-
2020Search for Heavy Resonances Decaying into a Photon and a Hadronically Decaying Higgs Boson in pp Collisions at root s=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 125.Full Text via DOI: 10.1103/PhysRevLett.125.251802 PMID: 33416363
-
2020Search for Higgs Boson Decays into a Z Boson and a Light Hadronically Decaying Resonance Using 13 TeV pp Collision Data from the ATLAS Detector. PHYSICAL REVIEW LETTERS. 125.Full Text via DOI: 10.1103/PhysRevLett.125.221802 PMID: 33315463
-
2020FREQUENCY AND MOLECULAR ASSOCIATIONS OF KRAS MUTATIONS IN GYNECOLOGIC MALIGNANCIES. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A158-A159.
-
2020ONCOLYTIC VACCINIA (OLVI-VEC) PRIMED IMMUNOCHEMOTHERAPY IN PLATINUM-RESISTANT/REFRACTORY OVARIAN CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A9-A10.Full Text via DOI: 10.1136/ijgc-2020-IGCS.12
-
2020Phase II VIRO-15 trial of olvimulogene nanivacirepvec (Olvi-Vec)-primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588). GYNECOLOGIC ONCOLOGY. 60-60.Full Text via DOI: 10.1016/j.ygyno.2020.06.126
-
2020The effect of intraperitoneal chemotherapy after interval cytoreductive surgery on recurrence and survival in patients with advanced-stage ovarian carcinoma. GYNECOLOGIC ONCOLOGY. 154-154.Full Text via DOI: 10.1016/j.ygyno.2020.05.219
-
2020Dijet Resonance Search with Weak Supervision Using root S=13 TeV pp Collisions in the ATLAS Detector. PHYSICAL REVIEW LETTERS. 125.Full Text via DOI: 10.1103/PhysRevLett.125.131801 PMID: 33034503
-
2020Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588). ANNALS OF ONCOLOGY. S628-S628.Full Text via DOI: 10.1016/j.annonc.2020.08.976
-
2020CP Properties of Higgs Boson Interactions with Top Quarks in the (tt)over-barH and tH Processes Using H -> gamma gamma with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 125.Full Text via DOI: 10.1103/PhysRevLett.125.061802 PMID: 32845699
-
2020Search for Heavy Higgs Bosons Decaying into Two Tau Leptons with the ATLAS Detector Using pp Collisions at root s=13 TeV. PHYSICAL REVIEW LETTERS. 125.Full Text via DOI: 10.1103/PhysRevLett.125.051801 PMID: 32794886
-
2020Measurement of the Lund Jet Plane Using Charged Particles in 13 TeV Proton-Proton Collisions with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 124.Full Text via DOI: 10.1103/PhysRevLett.124.222002 PMID: 32567910
-
2020Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 30:305-310.Full Text via DOI: 10.1136/ijgc-2019-000915 PMID: 31857439
-
2020Measurement of Azimuthal Anisotropy of Muons from Charm and Bottom Hadrons in pp Collisions at root s=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 124.Full Text via DOI: 10.1103/PhysRevLett.124.082301 PMID: 32167369
-
2020Search for Magnetic Monopoles and Stable High-Electric-Charge Objects in 13 Tev Proton-Proton Collisions with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 124.Full Text via DOI: 10.1103/PhysRevLett.124.031802 PMID: 32031842
-
2019A prospective randomized trial of intravenous ketorolac vs. acetaminophen administered with opioid patient-controlled analgesia in gynecologic surgery. GYNECOLOGIC ONCOLOGY. 155:468-472.Full Text via DOI: 10.1016/j.ygyno.2019.09.019 PMID: 31601494
-
2019Observation of Electroweak Production of a Same-Sign W Boson Pair in Association with Two Jets in pp Collisions root s=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 123.Full Text via DOI: 10.1103/PhysRevLett.123.161801 PMID: 31702349
-
2019FACTORS ASSOCIATED WITH EXTENDED SURVIVAL FOR PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER (PROC) TREATED WITH MODIFIED VACCINIA ONCOLYTIC VIROTHERAPY (VOV). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A58-A58.Full Text via DOI: 10.1136/ijgc-2019-IGCS.120
-
2019Observation of Light-by-Light Scattering in Ultraperipheral Pb plus Pb Collisions with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 123.Full Text via DOI: 10.1103/PhysRevLett.123.052001 PMID: 31491300
-
2019Comparison of Fragmentation Functions for Jets Dominated by Light Quarks and Gluons from pp and Pb plus Pb Collisions in ATLAS. PHYSICAL REVIEW LETTERS. 123.Full Text via DOI: 10.1103/PhysRevLett.123.042001 PMID: 31491254
-
2019Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis. GYNECOLOGIC ONCOLOGY. 154:53-59.Full Text via DOI: 10.1016/j.ygyno.2019.04.654 PMID: 31027899
-
2019Combination of Searches for Invisible Higgs Boson Decays with the ATLAS Experiment. PHYSICAL REVIEW LETTERS. 122.Full Text via DOI: 10.1103/PhysRevLett.122.231801 PMID: 31298882
-
2019Timing of postoperative Foley catheter removal fromrobotic-assisted radical hysterectomy in patients with early-stage cervical cancer. GYNECOLOGIC ONCOLOGY. 157-157.Full Text via DOI: 10.1016/j.ygyno.2019.04.369
-
2019
-
2019Search for the Production of a Long-Lived Neutral Particle Decaying within the ATLAS Hadronic Calorimeter in Association with a Z Boson from pp Collisions at root s=13 TeV. PHYSICAL REVIEW LETTERS. 122.Full Text via DOI: 10.1103/PhysRevLett.122.151801 PMID: 31050493
-
2019Search for doubly charged scalar bosons decaying into same-sign W boson pairs with the ATLAS detector. EUROPEAN PHYSICAL JOURNAL C. 79.Full Text via DOI: 10.1140/epjc/s10052-018-6500-y PMID: 30872971
-
2018Operation and performance of the ATLAS Tile Calorimeter in Run 1. EUROPEAN PHYSICAL JOURNAL C. 78.Full Text via DOI: 10.1140/epjc/s10052-018-6374-z PMID: 30872953
-
2018Combination of the Searches for Pair-Produced Vectorlike Partners of the Third-Generation Quarks at root s=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 121.Full Text via DOI: 10.1103/PhysRevLett.121.211801 PMID: 30517796
-
2018Observation of Centrality-Dependent Acoplanarity for Muon Pairs Produced via Two-Photon Scattering in Pb plus Pb Collisions at root s(NN)=5.02 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 121.Full Text via DOI: 10.1103/PhysRevLett.121.212301 PMID: 30517793
-
2018Search for Resonant and Nonresonant Higgs Boson Pair Production in the b(b)over-bar tau(+) tau(-) Decay Channel in pp Collisions at root s=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 121.Full Text via DOI: 10.1103/PhysRevLett.121.191801 PMID: 30468613
-
2018Probing the Quantum Interference between Singly and Doubly Resonant Top-Quark Production in pp Collisions at root s=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 121.Full Text via DOI: 10.1103/PhysRevLett.121.152002 PMID: 30362803
-
2018Measurement of the Soft-Drop Jet Mass in pp Collisions at root s=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 121.Full Text via DOI: 10.1103/PhysRevLett.121.092001 PMID: 30230903
-
2018Search for Low-Mass Dijet Resonances Using Trigger-Level Jets with the ATLAS Detector in pp Collisions at root s=13 TeV. PHYSICAL REVIEW LETTERS. 121.Full Text via DOI: 10.1103/PhysRevLett.121.081801 PMID: 30192593
-
2018Poster Session Paraaortic lymph node dissection pathology in patients with endometrial cancer undergoing robotic sentinel lymph node mapping (SLNM). GYNECOLOGIC ONCOLOGY. 109-109.Full Text via DOI: 10.1016/j.ygyno.2018.04.252
-
2018Recurrence patterns and survival in patients with endometrial cancer undergoing robotic sentinel lymph node mapping (SLNM). GYNECOLOGIC ONCOLOGY. 108-108.Full Text via DOI: 10.1016/j.ygyno.2018.04.249
-
2018Search for the Decay of the Higgs Boson to Charm Quarks with the ATLAS Experiment. PHYSICAL REVIEW LETTERS. 120.Full Text via DOI: 10.1103/PhysRevLett.120.211802 PMID: 29883151
-
2018Phase 1b study of oncolytic vaccinia virus GL-ONC1 in recurrent ovarian cancer (ROC).. JOURNAL OF CLINICAL ONCOLOGY.
-
2018Search for a Structure in the B-s(0) pi(+/-) Invariant Mass Spectrum with the ATLAS Experiment. PHYSICAL REVIEW LETTERS. 120.Full Text via DOI: 10.1103/PhysRevLett.120.202007 PMID: 29864314
-
2018Search for High-Mass Resonances Decaying to tau nu in pp Collisions at root s=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 120.Full Text via DOI: 10.1103/PhysRevLett.120.161802 PMID: 29756910
-
2017Search for Heavy Higgs Bosons A/H Decaying to a Top Quark Pair in pp Collisions at root s=8 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 119.Full Text via DOI: 10.1103/PhysRevLett.119.191803 PMID: 29219511
-
2017Search for Dark Matter Produced in Association with a Higgs Boson Decaying to b(b)over-bar Using 36 fb(-1) of pp Collisions at root s=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 119.Full Text via DOI: 10.1103/PhysRevLett.119.181804 PMID: 29219535
-
2017Performance of the ATLAS track reconstruction algorithms in dense environments in LHC Run 2. EUROPEAN PHYSICAL JOURNAL C. 77.Full Text via DOI: 10.1140/epjc/s10052-017-5225-7 PMID: 29081711
-
2017Identification and rejection of pile-up jets at high pseudorapidity with the ATLAS detector. EUROPEAN PHYSICAL JOURNAL C. 77.Full Text via DOI: 10.1140/epjc/s10052-017-5081-5 PMID: 32011613
-
2017Search for the Dimuon Decay of the Higgs Boson in pp Collisions at root s=13 TeV with the ATLAS Detector. PHYSICAL REVIEW LETTERS. 119.Full Text via DOI: 10.1103/PhysRevLett.119.051802 PMID: 28949725
-
2017A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer. ANNALS OF SURGICAL ONCOLOGY. 24:1972-1979.Full Text via DOI: 10.1245/s10434-017-5825-3 PMID: 28265777
-
2017Search for dark matter at root s=13 TeV in final states containing an energetic photon and large missing transverse momentum with the ATLAS detector. EUROPEAN PHYSICAL JOURNAL C. 77.Full Text via DOI: 10.1140/epjc/s10052-017-4965-8 PMID: 28781578
-
2017Patient care needs before and after robotic surgery for gynecologic cases in comparison to laparotomy. GYNECOLOGIC ONCOLOGY. 201-201.Full Text via DOI: 10.1016/j.ygyno.2017.03.462
-
2017Prognostic Significance of the Standardized Uptake Value of Pretherapeutic F-18-Labeled 2-Fluoro-2-Deoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Locally Advanced Cervical Cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 27:530-536.Full Text via DOI: 10.1097/IGC.0000000000000930 PMID: 28187100
-
2017A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study. GYNECOLOGIC ONCOLOGY. 144:101-106.Full Text via DOI: 10.1016/j.ygyno.2016.10.026 PMID: 28029447
-
2016Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. GYNECOLOGIC ONCOLOGY. 141:206-210.Full Text via DOI: 10.1016/j.ygyno.2016.02.018 PMID: 26905211
-
2015Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: A An NRG Oncology/Gynecologic Oncology Group Study 0229N. GYNECOLOGIC ONCOLOGY. 138:24-29.Full Text via DOI: 10.1016/j.ygyno.2015.04.006 PMID: 25888978
-
2015Physical Activity Levels Among Ovarian Cancer Survivors: An NRG Oncology/Gynecologic Group Study. MEDICINE & SCIENCE IN SPORTS & EXERCISE. 626-626.Full Text via DOI: 10.1249/01.mss.0000478423.79482.1a
-
2015Cervical cancer recurrence risk evaluation based on SUV(max) during initial F-18-FDG PET/CT. GYNECOLOGIC ONCOLOGY. 74-74.Full Text via DOI: 10.1016/j.ygyno.2015.01.180
-
2015Impact of sentinel lymph node mapping on FIGO stage and GOG risk stratification in early endometrial cancer: A comparative analysis. GYNECOLOGIC ONCOLOGY. 21-22.Full Text via DOI: 10.1016/j.ygyno.2015.01.050
-
2014The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer. EXPERT REVIEW OF ANTICANCER THERAPY. 1105-1113.Full Text via DOI: 10.1586/14737140.2014.956095 PMID: 25189201
-
2013Phase II trial of combination bevacizumab and temsirolimus in the treatment of A recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study. GYNECOLOGIC ONCOLOGY. 129:22-27.Full Text via DOI: 10.1016/j.ygyno.2012.12.022 PMID: 23262204
-
2012Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery. JOURNAL OF ROBOTIC SURGERY. 6:317-322.Full Text via DOI: 10.1007/s11701-011-0314-3 PMID: 27628471
-
2012Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study. GYNECOLOGIC ONCOLOGY. S17-S17.Full Text via DOI: 10.1016/j.ygyno.2011.12.041
-
2011Morbidity and mortality conference in obstetrics and gynecology: a tool for addressing the 6 core competencies.. Journal of graduate medical education. 100-3.Full Text via DOI: 10.4300/JGME-D-10-00093.1 PMID: 22379530
-
2010Robotic surgery in gynecologic oncology fellowship programs in the USA: a survey of fellows and fellowship directors. INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY. 6:405-412.Full Text via DOI: 10.1002/rcs.349 PMID: 20848676
-
2010Impact of a Weekly Multidisciplinary Tumor Board Conference on the Management of Women With Gynecologic Malignancies. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 20:1321-1325.Full Text via DOI: 10.1111/IGC.0b013e3181f5871e PMID: 21051971
-
2009The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: A retrospective cohort study. GYNECOLOGIC ONCOLOGY. 114:424-426.Full Text via DOI: 10.1016/j.ygyno.2009.05.031 PMID: 19552944
-
2009Effect of TRA-8 Anti-Death Receptor 5 Antibody in Combination With Chemotherapy in an Ex Vivo Human Ovarian Cancer Model. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 19:814-819.Full Text via DOI: 10.1111/IGC.0b013e3181a2a003 PMID: 19574765
-
2009Patterns of Failure for Conservatively Managed Surgical Stage I Uterine Carcinosarcoma Implications for Adjuvant Therapy. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 19:888-891.Full Text via DOI: 10.1111/IGC.0b013e3181a831fb PMID: 19574779
-
2009The Management of Cervical Intraepithelial Neoplasia During Pregnancy: Is Colposcopy Necessary?. JOURNAL OF LOWER GENITAL TRACT DISEASE. 13:182-185.PMID: 19550217
-
2009The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies. GYNECOLOGIC ONCOLOGY. 112:601-604.Full Text via DOI: 10.1016/j.ygyno.2008.10.025 PMID: 19110303
-
2008Conservative management of postoperative fever in gynecologic patients undergoing major abdominal or vaginal operations. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 207:393-397.Full Text via DOI: 10.1016/j.jamcollsurg.2008.04.001 PMID: 18722945
-
2008Development of an optimized conditionally replicative adenoviral agent for ovarian cancer. INTERNATIONAL JOURNAL OF ONCOLOGY. 32:1179-1188.PMID: 18497979
-
2008Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model. GYNECOLOGIC ONCOLOGY. 108:591-597.Full Text via DOI: 10.1016/j.ygyno.2007.11.039 PMID: 18177927
-
2007Treatment considerations in advanced endometrial cancer.. Current oncology reports. 494-8.PMID: 17991358
-
2007Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancers. GYNECOLOGIC ONCOLOGY. 614-621.Full Text via DOI: 10.1016/j.ygyno.2007.05.035 PMID: 17602728
-
2007New advances in vaccine technology and improved cervical cancer prevention. OBSTETRICS AND GYNECOLOGY. 1187-1192.PMID: 17470604
-
2007LUMA (TM) Cervical Imaging System. EXPERT REVIEW OF MEDICAL DEVICES. 4:121-129.Full Text via DOI: 10.1586/17434440.4.2.121 PMID: 17359219
-
2007Gene expression profiling of women with varying degrees of cervical intraepithelial neoplasia.. JOURNAL OF LOWER GENITAL TRACT DISEASE. 25-8.PMID: 17194947
-
2006Outcomes of gynecologic oncology patients admitted to the intensive care unit following surgery: a university teaching hospital experience. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 16:1766-1769.Full Text via DOI: 10.1111/j.1525-1438.2006.00702.x PMID: 17009969
-
2006Novel methods to treat and prevent human papillomavirus infection.. Expert review of anti-infective therapy. 593-600.PMID: 17009939
-
2006Use of a fascial prosthesis for management of abdominal compartment syndrome secondary to obstetric hemorrhage. OBSTETRICS AND GYNECOLOGY. 107:493-496.PMID: 16449161
-
2005Two cases of non-Hodgkin's lymphoma presenting as primary gynecologic malignancies. GYNECOLOGIC ONCOLOGY. 98:490-492.Full Text via DOI: 10.1016/j.ygyno.2005.04.033 PMID: 15993934
-
2005Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. GYNECOLOGIC ONCOLOGY. 98:309-312.Full Text via DOI: 10.1016/j.ygyno.2005.05.011 PMID: 15975642
Background
Full Name
- James Erasmus IV Kendrick, MD
Education
- University of Alabama School of Medicine, Birmingham, AL
Residency
- University of Alabama at Birmingham, AL
Fellowship
- University of Alabama at Birmingham, AL
Board Certification
- American Board of Obstetrics & Gynecology
Contact
primary email
- Research.Institute@AdventHealth.com